Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell entities : Intellia therapeutics, inc. save search
Intellia Therapeutics and Kyverna Therapeutics Announce Collaboration to Develop Next-Generation Allogeneic T-Cell Therapy for Autoimmune Diseases
Published: 2022-01-05 (Crawled : 12:30) - globenewswire.com
NTLA | $21.3 -0.93% -0.94% 1.1M
|
Health Technology
|
| O: -1.3%
H: 1.04%
C: -7.77%
therapeutics disease cel intel therapy collaboration t-cell
Intellia Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug Application for NTLA-5001, its CRISPR/Cas9-Engineered TCR-T Cell Candidate for Acute Myeloid Leukemia
Published: 2021-09-16 (Crawled : 11:33) - globenewswire.com
NTLA | $21.3 -0.93% -0.94% 1.1M
|
Health Technology
|
| O: 1.38%
H: 2.94%
C: 0.88%
new drug crispr fda fda acceptance myeloid leukemia drug leukemia t-cell acute myeloid leukemia
Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics Launch New CAR T-Cell Company
Published: 2021-06-22 (Crawled : 12:00) - biospace.com/
BX | $120.32 -2.33% -0.49% 5.7M
|
Finance
|
| O: 0.0%
H: 1.06%
C: 0.1%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.57%
H: 0.25%
C: -0.04%
NTLA | $21.3 -0.93% -0.94% 1.1M
|
Health Technology
|
| O: 2.25%
H: 0.49%
C: -2.58%
life science t-cell car-t
Intellia Therapeutics Presents New Preclinical Data Supporting Its CRISPR/Cas9-Engineered TCR-T Cell Treatment for Acute Myeloid Leukemia at the 62nd ASH Annual Meeting
Published: 2020-12-05 (Crawled : 15:00) - globenewswire.com
NTLA | $21.3 -0.93% -0.94% 1.1M
|
Health Technology
| Email alert
Add to watchlist
crispr leukemia treatment t-cell myeloid leukemia preclinical pre-clinical acute myeloid leukemia
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.